CIK 0001559053 · Accelerated filer
PROTHENA CORP PUBLIC LTD CO
Sign in to watch- Ticker
- PRTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ireland
- Entity type
- operating
- Phone
- 011-353-1-236-2500
- Business address
- 77 SIR JOHN ROGERSON'S QUAY, BLOCK C, GRAND CANAL DOCKLANDS, DUBLIN 2, Ireland, D02 VK60
- Former names
- Prothena Corp plc, Neotope Corp Ltd
- Open-market buys, last 90 days
- $9,848,721
- in 10 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$9,848,721. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-12-19 | SCULLY WILLIAM P 10% owner | Gift | −681,000 | 616,693 | ||
| 2024-12-18 | SCULLY WILLIAM P 10% owner | Gift | +430,000 | 1,224,257 | ||
| 2024-12-18 | SCULLY WILLIAM P 10% owner | Purchase | +73,436 | $13.93 | $1.0M | 1,297,693 |
| 2024-10-01 | Swanson Chad J. Chief Development Officer | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2024-05-15 | WELCH DANIEL G Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2024-05-15 | Selkoe Dennis J. Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2024-05-15 | Kim Helen Susan Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2024-05-15 | Ekman Lars Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2024-05-15 | Dunn William H. Jr. Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2024-05-15 | Cooke Shane Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2024-05-15 | COLLIER RICHARD T Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2024-05-15 | Cobb Paula K Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2024-03-01 | Ford David A Chief People Officer | Grant or award · Stock Option (Right to Buy) | +85,000 | 85,000 | ||
| 2024-02-27 | Zago Wagner M. Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +85,000 | 85,000 | ||
| 2024-02-27 | Walker Karin L Chief Accounting Officer | Grant or award · Stock Option (Right to Buy) | +54,000 | 54,000 | ||
| 2024-02-27 | Smith Brandon S. Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +85,000 | 85,000 | ||
| 2024-02-27 | Nguyen Tran Chief Strategy Officer and CFO | Grant or award · Stock Option (Right to Buy) | +85,000 | 85,000 | ||
| 2024-02-27 | Malecek Michael J Chief Legal Officer | Grant or award · Stock Option (Right to Buy) | +85,000 | 85,000 | ||
| 2024-02-27 | Kinney Gene G. President and CEO | Grant or award · Stock Option (Right to Buy) | +307,000 | 307,000 | ||
| 2024-02-27 | Karp Carol D. Chief Regulatory Officer | Grant or award · Stock Option (Right to Buy) | +85,000 | 85,000 |
Page 6 of 9 · 172 trades